Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
1 vehicle on file, newest listing first
Bruce E. Roberts, Director Bruce E. Roberts is a Managing Director at RM Global Partners LLC, or RMG, a specialized life sciences investment bank and asset management firm. Mr. Roberts has over 25 years of international banking, strategic, and investment experience in the life sciences sector. In addition to biopharma and consumer/digital health, he has specific expertise in medical technology and drug -device combination products. Mr. Roberts co -founded the business under RMG’s predecessor firm Roberts Mitani in the early 1990’s. He has completed multiple transactions in the life sciences space for clients including Micrus Endovascular (acquired by Johnson & Johnson, or JNJ), Encysive Pharmaceuticals (acquired by Pfizer), Anterios (acquired by Allergan) and MediBeacon, among many others, and has advised on life science investment strategies for corporate clients including Toyota, AmorePacific Group, and Cosmotec.
This record is keyed to SEC CIK 0001840983 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 46 institutional-holder rows on these vehicles, under 24 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.